(Q33417964)

26 July 2017

1 reference

title

Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness (English)

1 reference

26 July 2017

A Basire

1

1 reference

PubMed ID

25277423

26 July 2017

C Picard

series ordinal

2

1 reference

26 July 2017

30 September 2014

1 reference

Transfusion Clinique et Biologique

26 July 2017

1 reference

26 July 2017

21

1 reference

26 July 2017

4-5

1 reference

26 July 2017

193-206

1 reference

Human platelet antigens - 2013.

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Assessing the HLA diversity of cord blood units collected from a birth clinic caring for pregnant women in an ethnically diverse metropolitan area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

The presence of messenger RNA for HLA class I in human platelets and its capability for protein biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Clinical relevance of the HLA system in blood transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Platelet transfusion refractoriness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

The role of HLA antibodies in allogeneic SCT: is the 'type-and-screen' strategy necessary not only for blood type but also for HLA?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Platelet alloantibodies in transfused patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

[Prevalence of platelet-specific antibodies in the recipients of platelet units with transfusion adverse event]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Laboratory testing for platelet antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Molecular typing of human platelet and neutrophil antigens (HPA and HNA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Luminex(®) and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Platelet antibody detection by flow cytometry: an effective method to evaluate and give transfusional support in platelet refractoriness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Identification of anti-HPA-1a allo-antibodies using IgG platelet antibody detection and crossmatch system assay with Galileo Echo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

A new bead-based human platelet antigen antibodies detection assay versus the monoclonal antibody immobilization of platelet antigens assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

HLA antibody detection with solid phase assays: great expectations or expectations too great?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Determinants of C1q binding in the single antigen bead assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

"Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Antibodies to HLA-E in nonalloimmunized males: pattern of HLA-Ia reactivity of anti-HLA-E-positive sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

HLA antibody specification using single-antigen beads--a technical solution for the prozone effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

The mean fluorescence intensities of anti-HLA antibodies detected using micro-bead flow cytometry predict the risk of platelet transfusion refractoriness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Platelet transfusion refractoriness caused by a mismatch in HLA-C antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Anti-HLA alloantibodies in surgical patients refractory to platelet transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2014.08.140

10.1016/J.TRACLI.2014.08.140

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

25277423